Title: Dietary advice for newly diagnosed cases of rheumatoid arthritis

 

Key words: rheumatoid arthritis, RA, NSAIDs, steroids, immunotherapy, dietary therapy, dietary interventions, compliance, nutritional,exclusion diets, IgE, allergy, food intolerance, fasting, remission, vegan, lactovegetarian diets, intolerances,  supplements, wheat, corn, dairy, pork, mucosal damage, vitamins, immune-mediated, dysbiosis, inflammation, inflammatory, anti-inflammatory, mineral, antioxidant, malabsorption, H. pylori, hypochlorhydria, essential fatty acids, EFA, N-3 PUFA, polyunsaturated fatty acids, eicosanoids, fish oils, zinc, selenium, testosterone, oestrogen, progesterone, menopausal, herbal, curcumin, ginger, Boswellia, Chinese, Ayurvedic,

 

Date: Sept 2006

 

Category: Specific conditions

 

Nutrimed Module:

 

Type: Article

 

Author: Morgan, G

 

Dietary advice for newly diagnosed cases of rheumatoid arthritis

 

Conventional treatment of RA with NSAIDs, steroids and immunotherapy continues to pose problems in terms of patient response and compliance. Much evidence has now accumulated on the potential beneficial effects of dietary therapy in the management of RA. Given the relapsing and variable course of RA and the desire of many patients to retain a greater degree of control over their disease, dietary advice at presentation is to be recommended. Advice should be informed and based on the work that has been done on exclusion diets and nutritional supplements.

 

Exclusion diets

Though IgE mediated allergy has not been shown to be important (Darlington 1987, Panush 1990), there is much evidence to indicate that non-classical pathways of food intolerance can play a major role in the evolution and maintenance of RA (Darlington 1986, Darlington 1991, van de Laar 1992, Kavanagh 1995). In removing these factors, fasting is able to promote remissions in active disease (Kroker 1984, Hafstrom 1988). Studies show that introduction of sensitising foods such as wheat, corn, dairy and pork, following fasting or elimination, frequently produce relapses and have been reported to be significant factors in 35-40% of cases (Kjeldsen-Kragh 1991, Darlington 2003). Vegan and lactovegetarian diets have been found to be particularly helpful in excluding these intolerances (Kjeldsen-Kragh 1991, Nenonen 1998).

 

Food allergies and NSAID use has been linked to mucosal damage and the ‘leaky gut’ syndrome (Bjarnason 1984). Dysbiosis, related to overgrowth of pathological bacteria including Proteus and Clostridia organisms is a frequent accompaniment in RA (Mannson 1966, Ebringer 1985) and is associated with local toxic damage to the mucosa, malabsorption and vitamin, mineral and antioxidant deficiencies. Food allergies with these deficiencies combine to exacerbate the immune-mediated inflammatory processes of RA. Modulation of these factors by an appropriate exclusion diet and avoidance of NSAIDs is therefore potentially of prime importance in the control of the disease.

 

Dietary advice should be preceded by exclusion of celiac disease and H. pylori infection. In one study (O’Farrelly 1988) 48% of RA cases were associated with a degree of villous atrophy secondary to gluten intolerance. H. pylori, present in over 50% of the population, is associated with hypochlorhydria. Both are associated with mucosal damage, food intolerances, malabsorption and vitamin, mineral and antioxidant deficiencies.

 

Dietary supplementation

Much work has been done looking at the effect of essential fatty acids in RA (Sperling 1987, Kremer 1987, Belch 1988, Bregski 1991). Most have shown positive effects, effects thought to be mediated though eicosanoid pathways. N-3 PUFAs in fish oils have been found to be most effective and are thought to act by suppressing the proinflammatory LTB4 and promoting the anti- inflammatory LTB5 leukotrienes (Sperling 1987, Kremer 1987). Large doses of at least 12g of MaxEPA were used in these trials however. Cost considerations and the unknown efficacy of lower doses might counsel against recommending fish oils to patients. In addition concerns have been expressed about the long-term use of n-3 PUFAs due to their possible inhibition of antioxidant and immune function (Meydani 1991, Sanders 1992, Meydani 1993, Hughes 1995). N-6 and n-9 PUFAs appear to possess lesser anti-inflammatory action but may have a place in potentiating the effect of fish oils.

 

Zinc and selenium deficiency is common in RA but appears not to respond to supplementation (Honkanen 1991, Tarp 1985). Age related effects associated with malabsorption and hormonal changes lead to a progressive decline in these and other antioxidant and anti-inflammatory nutrients: women are less well protected by testosterone and by declining oestrogen and progesterone levels around the menopause than men (Wilder 2000). Given the synergistic action of such factors in inflammatory and degenerative disorders, it seems only wise to recommend vitamin and mineral supplementation in RA, especially for premenopausal women. Many herbal products have been shown to possess antioxidant and anti- inflammatory effects though these have been less well researched. Several such as Curcumin, Ginger and Boswellia have been used in traditional Chinese and Ayurvedic medicine for many years. Research has shown that they exert part of their effect through the same eicosanoid pathways as the PUFAs (Sristava 1989, Kuichi 1992, Ammon 1993). Suitable preparations are now available in the West in tablet form.

 

Summary

Research has now confirmed that a subset of RA patients do respond to dietary and nutritional supplement measures. Many of the pathways for these actions are now known. Newly presenting RA patients should be made aware of the drawbacks of conventional treatments and the alternatives. For those that are receptive and who are willing to forebear a degree of inconvenience and expense the above treatment strategies have much to offer.

 

References

1. Darlington LG, Ramsey NW ((1987) Weight loss, IgE levels and fish oils in rheumatoid arthritis. In: Machtey I (ed.) Progress in rheumatology III pp. 137-40. Patah-Tiqva, Israel: Rheumatology Service, Golden Medical Centre

2. Panush RS (1990) Food induced (‘allergic’) arthritis: clinical and serologic studies. J Rheumatol 17: 291-4

3. Darlington LG, Ramsey NW, Mansfield JR (1986) Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet i: 236-8

4. Darlington LG, Ramsey RW (1991) Diet for rheumatoid arthritis. Lancet 338: 1209 5. van de Laar MA, van der Korst JK (1992) Food intolerance in rheumatoid arthritis. A double blind, controlled trial of the clinical effects of elimination of milk allergens and azo dyes. Ann Rheum Dis 51: 303-6

6. Kavanagh R, et al. (1995) The effects of elemental diet and subsequent reintroduction on rheumatoid arthritis. Br J Rheumatol 34: 270-3

7. Kroker GF, et al. (1984) Fasting and rheumatoid arthritis: A multicentre study. Clin Ecol 2: 137-44

8. Hafstrom I, et al. (1988) Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis. Arthritis Rheum 31: 585-90

9. Kjeldsen-Kragh J, et al. (1991) Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 338: 899-902

10. Darlington LG (2003) Lecture notes. Personal experience, Epsom Hospital, Department of Rheumatology. Surrey University

11. Nenonen MT, Helve TA, Rauma AL, Hanninen OO (1998) Uncooked, lactobacilli-rich, vegan food and rheumatoid arthritis. Br J Rheumatol 37: 274-81

12. Bjarnason I, et al. (1984) Intestinal permeability and inflammation in rheumatoid arthritis: Effects on non-steroidal anti-inflammatory drugs. Lancet ii: 1171-4

13. Mannson I, Olhagen B (1966) Intestinal Clostridium perfringens in rheumatoid arthritis and other connective tissue disorders. Acta Rheum Scand 12: 167-74

14. Ebringer A, et al. (1985) Antibodies to Proteus in rheumatoid arthritis. Lancet ii:305-7

15. O’Farrelly C, et al. (1988) Association between villous atrophy in rheumatoid arthritis and a rheumatoid factor and gliadin-specific IgG. Lancet ii: 819-22

16. Sperling RI, et al. (1987) Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum 30: 988-97

17. Kremer JM, et al. (1987) Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled crossover study. Ann Intern Med 106: 497-503

18. Belch JJ, Ansell D, Madhock R, O’Dowd A, Sturrock RD (1988) Effects of altering dietary essential fatty acids on requirements for non-steroidal steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis 47: 96-104

19. Bregski M, Madhock R, Capell HA (1991) Evening primrose oil in and patients with rheumatoid arthritis and side effects of non- steroidal anti-inflammatory drugs. Br J Rheumatol 30: 370-2

20. Meydani M, et al. (1991) Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J Nutr 121: 484-91

21. Sanders TA, Hinds A (1992) The influence of a fish oil high in docoso- hexaenoic acid on plasma lipoprotein and vitamin E concentration and haemostatic function in healthy male volunteers. Br J Nutr 68: 163-73

22. Meydani SN, et al. (1993) Immunological effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest 92: 105-13

23. Hughes DA, Pinder AC, Piper Z, Lund EK (1995) N-3 polyunsaturated fatty acids (PUFA) modulate the expression of functionally associated molecules on human monocytes. Biochem Soc Trans 23: 303S

24. Honkanen VEA, et al. (1991) Plasma zinc and copper concentrations in rheumatoid arthritis: influence of dietary factors and disease activity. Am J Clin Nutr 54: 1082-6

25. Tarp U, Overvad K, Thorling EB, Graudal H, Hansen JC (1985) Selenium treatment in rheumatoid arthritis. Scand J Rheumatol 14: 364-8

26. Wilder RL (1996) Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. J Rheumatol 44: 10-12

27. Srivastava KC, Mustafa T (1989) Ginger (Zingiber officinale) and rheumatic disorders. Medical Hypotheses 29: 25-28

28. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U (1992) Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull 40: 387-391

29. Ammon HPT, Safayhi H, Mack T, Sabieraj J (1993) Mechanism of anti-inflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 38: 113-119